ArchiMed

ArchiMed SAS is a private equity firm specializing investing in buyouts and growth capital of small to mid cap companies and lower mid-market. The firm seeks to invest in small and medium-sized companies in the healthcare sector with a focus on care and wellness including homecare, wellness centers, telemedicine, and hospital outsourcing services; medtech including medical devices and disposables, implants, diagnostics, healthcare information technology, life science tools, hygiene products, and medtech distributors; biopharma including specialty bioPharma companies, active pharmaceutical ingredients producers, contract manufacturing, animal health, contract research organizations, medical affairs, OTC products and wellness product manufacturers; and public health including health at work, food safety, environmental security, forensic. It prefers to invest in Europe with a focus on Western Europe including France, the United Kingdom, and Switzerland. The firm typically invests between €5 million ($6.22 million) and €15 million ($18.65 million) per transaction but the full range for the firm is between €2 million ($2.49 million) to €50 million ($59.7 million) or higher, alone or with co-investors. It invests in companies with revenues between €5 million ($6.22 million) and €100 million ($124.33 million), but with the ability to go beyond. The firm takes both minority and majority stakes, mostly in unlisted companies. ArchiMed SAS was founded in 2014 and is based in Lyon, France with an additional office in Paris, France.
LA

Ludovic Alonzi

Senior Associate

RF

Robin Filmer-Wilson

Managing Partner

Vincent Guillaumot

Founder and Managing Partner

LK

Loïc Kubitza

Operating Partner

SL

Sandrine Laporte

CFO

SM

Stefano Munnia

Private Equity Analyst

Denis Ribon

Chairman and Managing Partner

LD

Luca Di Santo

Associate Director

CS

Clotilde Schnepp

Senior Analyst

BV

Benoît Varichon

Director

Past deals in Consulting

Bomi Group

Acquisition in 2019
Bomi Italia S.p.A. provides logistics and management services for products related to health protection. The company offers warehousing, transportation, return management, reverse logistics, and consignment stock management services, as well as satellite stock solutions. It also provides orthopedic kits management services, including collection, decontamination, control, and delivery services. The company distributes medical products and devices to professional institutions, including hospitals, clinics, and laboratories, as well as to patients’ homes. It operates in 20 countries worldwide. The company was founded in 1985 and is headquartered in Vaprio d’Adda, Italy.

Provepharm life Solutions

Acquisition in 2018
Provepharm life Solutions is a truly unique life sciences research and pharma company, dedicated to a new era of discovery. We are a new global leader in human health with new Life Solutions, manufactured and developed from our core technology: Molecule Vitalization. As PROVEPHARM LIFE SOLUTIONS, we are building a new powerhouse for Research Services, Manufacturing Services and Speciality Care.

Stragen Healthcare Group

Acquisition in 2021
Stragen is an international, privately held healthcare company focused on the development, registration and worldwide distribution of:- pharmaceutical specialties for Women’s Health, Hospital Supplies and Biosimilars- consumer health products- new patented molecules from laboratory to proof of concept Stragen offers a large portfolio specialising in cardiology, infectiology, neurology, hematology and women’s health.

SUANFARMA, S.A.

Acquisition in 2021
SUANFARMA, S.A. engages in the development, manufacture, and distribution of raw materials and finished dosage forms for pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic sectors. The company offers generics and active pharmaceutical ingredients, such as anti-infective, cardiovascular system, central nervous system, digestive system, endocrine system, oncology, respiratory system, and pain and inflammation products; and food supplements, and medicinal and dietary plants, including non-native vegetable species, dietary supplements, plant extracts, jellies, syrups, oligotherapy, litotherapy, etc. It also provides active ingredients for veterinary industry, such as antibiotics, NSAIDs, antiparasitics, glucocorticoids, nutritional, reproduction, and others; and develops alternative routes of synthesis for obtaining active pharmaceutical ingredients and their subsequent industrial scale-up. In addition, the company invests in seed and early-stage biotechnology companies; delivers its expertise to biotech companies on issues related to business and commercial management; and provides support on scientific, industrial, regulatory, and financial development. It serves customers in Spain and internationally. The company was founded in 1993 and is based in Alcobendas, Spain. It has locations in Phoenix, Arizona; Fair Lawn, New Jersey; Naucalpan de Juárez, Mexico; Bogotá, Colombia; Caracas, Venezuela; Sao Paulo, Brazil; Buenos Aires, Argentina; Santiago, Chile; Madrid and Barcelona, Spain; Fitbourg, Switzerland; Dubai, United Arab Emirates; Navi Mumbai, India; and Shanghai, China.

NAMSA

Acquisition in 2020
NAMSA is a medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, they provide strategic guidance and tactical support to help clients commercialize medical products in the major markets of the world. They serve as your trusted partner, using their insight to identify strategies for saving time, while never compromising quality. They know that compromised quality can quickly take your product right back to the starting line. That’s why it’s so important to have a smart strategy from the outset—and why they put it at the forefront of every project.

Clean Cells

Venture Round in 2018
Clean Cells SAS offers services for quality control, training, and product development including biobanking for research, clinical, and GMP biomanufacturing. The company offers in vivo, in vitro, and custom-made tests required by international regulatory bodies to ensure the safety of biological products at all steps of the production. Clean Cells also offers Cellbanking services and stores cells in liquid and gaseous nitrogen in a protected environment. The company was founded in 2000 and is based in Boufféré, France.

Deallus Consulting

Acquisition in 2015
Deallus Consulting Ltd. operates as a life science consulting company. The company offers consulting advice in the areas of product strategy, corporate strategy, research and development, business development, manufacturing and supply strategy, and competitive analysis. It serves customers worldwide. The company was founded in 2004 and is based in London, United Kingdom. It has regional offices in Europe, North America, and the Asia Pacific.

Soest Medical Group

Acquisition in 2018
SMG is short for Soest Medical Group, a group of companies specialised in the field of medical supplies based in the Netherlands. In fact, it stands for “Connecting with Care” in different ways: - It is their main priority to stay connected and care about their customers. Together they develop and optimise their standard and customised products. - Their core business connects us to the medical industry. In close cooperation with universities and hospitals they research the possibilities for product improvement and expansion of thier product line. - The self-adhesive products serve to protect the human body by securing drapes to the patients’ skin during surgery.

Micromed S.p.A.

Acquisition in 2016
Micromed S.p.A. designs, develops, and manufactures electro medical devices for neurophysiology diagnostics. It offers EEG and sleep systems, EMG/EP systems, electrical stimulators, software, and accessories. The company’s products are used for digital EEG (EEG, video EEG, and stereo EEG), holter poligraphy, evoked potential, electromyography, and polysomnography testing. It serves laboratories of neurophysiology, neurology, child neurology, epilepsy, and sleep centers, as well as rehabilitation and ICU departments. Micromed S.p.A. was founded in 1982 and is based in Venice, Italy with operations internationally.

Citieffe s.r.l.

Venture Round in 2014
Citieffe s.r.l. develops, manufactures and sells innovative and patented products such as intramedullary nails for trochanter fractures or sophisticated reconstruction-focused external fixation devices.

Diesse

Acquisition in 2019
Diesse is an Italian developer of innovative in vitro diagnostic (‘IVD’) systems for the diagnosis of infectious and autoimmune diseases.

RehabWorks Ltd.

Acquisition in 2015
Vita Health Group Limited, a medical organization, provides injury management and rehabilitation services for industry and insurance sectors. The company offers preventative, occupational health, physiotherapy, psychological therapy, case management, and functional restoration services. It provides insurers, solicitors, government, and employers with clinical and vocational case management and rehabilitation services; and non-surgical and drug-free treatment for knee pain, back pain, and other musculoskeletal disorders. Vita Health Group Limited was formerly known as RehabWorks Limited and changed its name to Vita Health Group Limited in July 2019. The company was founded in 1987 and is based in Bury St. Edmunds, United Kingdom.

Xpress Biologics

Acquisition in 2021
Xpress Biologics is a company providing a large range of services from the design of expression systems to pre-clinical productions. As a One-Stop-Shop, Xpress Biologics can also ensure the management of clinical trials.

Primo Group SPA

Private Equity Round in 2015
Primo Group SPA provides dental services. The company offers services in the areas of oral hygiene, invisalign, installations, prostheses, and child orthodontics. The company was founded in 2010 and is based in Turin, Italy.

Centri Dentistici Primo

Venture Round in 2015
Trust is the basis of every relationship. First knows. Our method of care is based on absolute seriousness and transparency to reach a clear and sincere relationship with the patient.

Herb's International Service

Acquisition in 2016
Herb's International Service is a French leader in natural health ingredients. A team of 25 people who are passionate with botanicals. An agile company expert in sourcing herbal raw material. Sourcing means genuine quality, traceability, environment and ethical practices. We are audited each year by Ecocert and we have been granted the excellence label as a responsible company. We believe in partnership and work closely with our farmers, contract manufacturers to deliver the best ingredients to our customers. We design many type of natural ingredients using our raw material and we share our expertise with you. Service is key for us. We are dedicated to your projects.

Direct Healthcare Services Ltd

Acquisition in 2019
Direct Healthcare Group is is a fully integrated developer and manufacturer of a range of innovative pressure care products designed to prevent medical issues such as pressure sores, which can lead to serious, sometimes life threatening diseases.

ActiGraph, LLC

Acquisition in 2020
ActiGraph, LLC develops wearable ambulatory monitoring technology. It also develops software, data analytics, and management solutions. It offers activity monitors, centrepoint insight watch, actigraph GT9X link, wGT3X-BT, activity monitor comparsion; centrepoint, centrePoint platform, centrepoint data hub; actilife; and accessories. The company was incorporated in 2004 and is based in Pensacola, Florida.

EuroLyser

Acquisition in 2019
EuroLyser develops point-of-care testing devices and kits. We are convinced that medical diagnostics are a key element of modern day healthcare. The faster and more precise a doctor can determine what the patient needs, the faster they can commence treatment.

Polyplus-transfection SA

Acquisition in 2016
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Fytexia SAS

Acquisition in 2016
Fytexia is a supplier of innovative ingredient. Our innovative and clinically proven solutions provide health benefits. SUPPLIER OF NATURAL AND SCIENTIFICALLY PROVEN INNOVATIVE INGREDIENTS TO THE NUTRACEUTICAL INDUSTRY. Located in South of France on the Mediterranean Sea, Fytexia offers natural ingredients to the food supplement industry. Our innovative and clinically proven solutions provide health benefits from the Mediterranean diet to humans, worldwide.